Grey Wolf Animal Health Corp. (WOLF : TSX-V)
Common Stock
$1.68
CAD
+0.08 (5.00%)
Last updated: 2026-07-20
WOLF
Grey Wolf Animal Health Corp.
WealthAwesomePerformance
1 Day
+5.00%
1 Week
-5.08%
1 Month
-6.15%
YTD
+26.32%
Key Statistics
Market Cap
$55.19M
52W High
$1.85
52W Low
$1.00
P/E Ratio
32.00
50 Day MA
$1.71
200 Day MA
$1.45
Beta
0.45
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/20/2026 | $1.72 | $1.72 | $1.68 | $1.68 | $1.68 | 576 |
| 7/15/2026 | $1.61 | $1.61 | $1.60 | $1.60 | $1.60 | 4,416 |
| 7/14/2026 | $1.60 | $1.60 | $1.60 | $1.60 | $1.60 | 600 |
| 7/13/2026 | $1.78 | $1.85 | $1.77 | $1.77 | $1.77 | 5,200 |
| 7/10/2026 | $1.65 | $1.77 | $1.60 | $1.75 | $1.75 | 7,629 |
| 7/8/2026 | $1.77 | $1.78 | $1.77 | $1.78 | $1.78 | 312 |
| 7/6/2026 | $1.78 | $1.78 | $1.77 | $1.78 | $1.78 | 5,805 |
| 7/3/2026 | $1.75 | $1.75 | $1.75 | $1.75 | $1.75 | 0 |
| 7/2/2026 | $1.75 | $1.75 | $1.75 | $1.75 | $1.75 | 5,014 |
| 6/30/2026 | $1.75 | $1.79 | $1.75 | $1.75 | $1.75 | 10,400 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WOLF's historical volatility
30-Day Vol
53.5%
Annualized
90-Day Vol
56.3%
Annualized
Trend (90d)
+36.5%
Annualized drift
90d Mean
C$1.91
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.75 | C$1.46 – C$2.11 |
| 60 trading days | C$1.83 | C$1.41 – C$2.38 |
| 90 trading days | C$1.91 | C$1.39 – C$2.64 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Grey Wolf Animal Health Corp.
Grey Wolf Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedative analgesic and reversing agents for companion animals under the SEDAJECT and ATAJECT names; prescription drugs under the THYRO-TABS CANINE name; and wound care products, including medical grade tubes, viscose net dressings, alginate dressing, absorbent foam dressing, superabsorbent dressing, and silicone perforated tapes, as well as medical pet shirt protective wear products, such as pet shirt, pets boot, head cover, and leg sleeves. It also offers disposables comprising syringes, needles, and IV catheters; and nutraceuticals, as well as equine health products. The company was formerly known as Grey Wolf Animal Health Corp. and changed its name to Grey Wolf Health Corp. in June 2026. The company is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $36.60M
- EBITDA
- $6.83M
- Profit Margin
- 4.85%
- ROE (TTM)
- 5.93%
- EPS (Diluted)
- 0.05
- Book Value
- 0.90
Classification
- Sector
- Consumer Discretionary
- Industry
- Diversified Consumer Services
- Group
- Consumer Services
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE Report